Search Results - "Ul Amin, Toufiq"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
  2. 2

    Peripherally restricted transthyretin-based delivery system for probes and therapeutics avoiding opioid-related side effects by Tuhin, Md Tariqul Haque, Liang, Dengpan, Liu, Fang, Aldawod, Hala, Amin, Toufiq Ul, Ho, Joshua S., Emara, Rasha, Patel, Arjun D., Felmlee, Melanie A., Park, Miki S., Uchizono, James A., Alhamadsheh, Mamoun M.

    Published in Nature communications (23-06-2022)
    “…Several investigations into the sites of action of opioid analgesics have utilized peripherally acting mu-opioid receptor antagonists (PAMORAs), which have…”
    Get full text
    Journal Article
  3. 3

    Enhancing the Pharmacokinetic Profile of Interleukin 2 through Site-Specific Conjugation to a Selective Small-Molecule Transthyretin Ligand by Liu, Fang, Ul Amin, Toufiq, Liang, Dengpan, Park, Miki S, Alhamadsheh, Mamoun M

    Published in Journal of medicinal chemistry (14-10-2021)
    “…Protein drugs hold great promise as therapeutics for a wide range of diseases. Unfortunately, one of the greatest challenges to be addressed during clinical…”
    Get full text
    Journal Article
  4. 4

    Hydrophilic Small Molecules That Harness Transthyretin To Enhance the Safety and Efficacy of Targeted Chemotherapeutic Agents by Pal, Arindom, Albusairi, Wabel, Liu, Fang, Tuhin, Md Tariqul Haque, Miller, Mark, Liang, Dengpan, Joo, Hyun, Amin, Toufiq Ul, Wilson, Elizabeth A, Faridi, Jesika S, Park, Miki, Alhamadsheh, Mamoun M

    Published in Molecular pharmaceutics (01-07-2019)
    “…The hydrophobicity of many chemotherapeutic agents usually results in their nonselective passive distribution into healthy cells and organs causing collateral…”
    Get full text
    Journal Article
  5. 5

    Incorporating Glutamic Acid-Valine-Citrulline Linker in Trifunctional Molecules Targeting PSMA Ensures Enhanced Stability, Safety, and Efficacy in Mouse Model of Prostate Cancer by Amin, Toufiq Ul

    Published 01-01-2022
    “…This project describes the development of a new antitumor therapeutic platform that combines the benefits of small-molecule drug conjugates (SMDCs) and…”
    Get full text
    Dissertation